DaVita Inc DVA

Morningstar Rating
$176.81 +1.46 (0.83%)
View Full Chart

Company Report

Price vs Fair Value

DVA is trading at a LOCK|<><QHd@ premium.
Price
$176.81
Fair Value
Hg$
Uncertainty
LOCK|#^
1-Star Price
LOCK|%.w?n
5-Star Price
qw
Economic Moat
LOCK|bd@t
Capital Allocation
LOCK|&#%Y!s!

Bulls Say, Bears Say

Bulls

Despite recent covid mortality challenges and obesity drug expansion, the ESRD patient population may grow at a healthy rate in the US and around the globe in the long run, which should benefit DaVita.

Bears

Potential US healthcare policy changes could reduce industry profitability if insurance coverage shifts away from employer-based plans or if Medicare reimbursement rates don't increase substantially.

News

Articles & Videos

Trading Information

Previous Close Price
$175.35
Day Range
$171.78–177.48
52-Week Range
$101.00–247.49
Bid/Ask
$174.50 / $178.00
Shares Outstanding
63.80M
Market Cap
$11.28B
Volume/Avg
1M / 778,247

Key Statistics

Price/Earnings (Normalized)
13.79
Price/Sales
0.88
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
13.83%

Company Profile

DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Core
Total Number of Employees
78,000

Competitors

Valuation

Metric
DVA
FMS
THC
Price/Earnings (Normalized)
13.798.6813.92
Price/Book Value
—0.804.65
Price/Sales
0.880.531.03
Price/Cash Flow
5.443.915.47
Price/Earnings
DVA
FMS
THC

Financial Strength

Metric
DVA
FMS
THC
Quick Ratio
1.330.681.22
Current Ratio
1.471.071.41
Interest Coverage
3.474.765.71
Quick Ratio
DVA
FMS
THC

Profitability

Metric
DVA
FMS
THC
Return on Assets (Normalized)
7.71%4.50%5.60%
Return on Equity (Normalized)
—10.75%39.08%
Return on Invested Capital (Normalized)
12.79%6.66%10.73%
Return on Assets
DVA
FMS
THC

Medical Care Facilities Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Genesis Healthcare Inc Class A
GENNQ
LOCK|R#>LOCK|%y—
HCA Healthcare Inc
HCA
LOCK|X<H@d@LOCK|<$<<$99B
Fresenius SE & Co KGaA ADR
FSNUY
—LOCK|#FW?#$29B
Fresenius SE & Co KGaA Registered Shares
FSNUF
—LOCK|<l@?$29B
Tenet Healthcare Corp
THC
LOCK|SX@Bg%KLOCK|?cSm$22B
Encompass Health Corp
EHC
—LOCK|!$Cg!$12B
Fresenius Medical Care AG
FMCQF
—LOCK|#BR%$11B
Fresenius Medical Care AG ADR
FMS
LOCK|Zyy>ZK^LOCK|Lv<q$11B
Universal Health Services Inc Class B
UHS
LOCK|tGKHMrdLOCK|%Z$%$11B

Sponsor Center